Profund Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $663K | Sell |
3,499
-101
| -3% | -$19K | 0.02% | 458 |
|
|
2026
Q1 | $710K | Sell |
3,600
-23,436
| -87% | -$4.52M | 0.03% | 445 |
|
|
2025
Q4 | $4.97M | Buy |
27,036
+2,342
| +9% | +$411K | 0.15% | 102 |
|
|
2025
Q3 | $3.79M | Sell |
24,694
-1,782
| -7% | -$270K | 0.12% | 117 |
|
|
2025
Q2 | $3.7M | Buy |
26,476
+3,407
| +15% | +$477K | 0.13% | 114 |
|
|
2025
Q1 | $3.39M | Sell |
23,069
-1,482
| -6% | -$214K | 0.15% | 109 |
|
|
2024
Q4 | $3.22M | Buy |
24,551
+1,943
| +9% | +$272K | 0.12% | 125 |
|
|
2024
Q3 | $3.52M | Sell |
22,608
-1,994
| -8% | -$322K | 0.13% | 114 |
|
|
2024
Q2 | $3.84M | Sell |
24,602
-187
| -0.8% | -$28.1K | 0.14% | 106 |
|
|
2024
Q1 | $3.36M | Sell |
24,789
-1,729
| -7% | -$229K | 0.13% | 119 |
|
|
2023
Q4 | $3.57M | Buy |
26,518
+3,555
| +15% | +$462K | 0.15% | 114 |
|
|
2023
Q3 | $3.11M | Buy |
22,963
+5,040
| +28% | +$688K | 0.17% | 102 |
|
|
2023
Q2 | $2.57M | Sell |
17,923
-992
| -5% | -$146K | 0.14% | 117 |
|
|
2023
Q1 | $2.63M | Sell |
18,915
-311
| -2% | -$41.8K | 0.16% | 107 |
|
|
2022
Q4 | $2.61M | Buy |
19,226
+841
| +5% | +$105K | 0.17% | 111 |
|
|
2022
Q3 | $2.02M | Sell |
18,385
-1,168
| -6% | -$148K | 0.15% | 130 |
|
|
2022
Q2 | $2.58M | Sell |
19,553
-3,736
| -16% | -$490K | 0.16% | 117 |
|
|
2022
Q1 | $3.09M | Buy |
23,289
+15,466
| +198% | +$1.85M | 0.13% | 134 |
|
|
2021
Q4 | $911K | Buy |
7,823
+18
| +0.2% | +$2.12K | 0.03% | 358 |
|
|
2021
Q3 | $938K | Buy |
7,805
+325
| +4% | +$37.8K | 0.03% | 380 |
|
|
2021
Q2 | $896K | Buy |
7,480
+199
| +3% | +$21.8K | 0.03% | 390 |
|
|
2021
Q1 | $724K | Buy |
7,281
+257
| +4% | +$25.8K | 0.03% | 415 |
|
|
2020
Q4 | $702K | Buy |
7,024
+677
| +11% | +$71.7K | 0.03% | 414 |
|
|
2020
Q3 | $696K | Sell |
6,347
-1,800
| -22% | -$200K | 0.04% | 364 |
|
|
2020
Q2 | $862K | Buy |
8,147
+1,478
| +22% | +$153K | 0.05% | 290 |
|
|
2020
Q1 | $596K | Sell |
6,669
-2,043
| -23% | -$192K | 0.04% | 313 |
|
|
2019
Q4 | $869K | Sell |
8,712
-2,222
| -20% | -$209K | 0.04% | 393 |
|
|
2019
Q3 | $975K | Sell |
10,934
-1,460
| -12% | -$127K | 0.05% | 341 |
|
|
2019
Q2 | $1.02M | Buy |
12,394
+172
| +1% | +$13.5K | 0.05% | 360 |
|
|
2019
Q1 | $988K | Buy |
12,222
+2,003
| +20% | +$158K | 0.05% | 340 |
|
|
2018
Q4 | $776K | Sell |
10,219
-4,081
| -29% | -$319K | 0.05% | 340 |
|
|
2018
Q3 | $1.13M | Sell |
14,300
-250
| -2% | -$18.9K | 0.04% | 356 |
|
|
2018
Q2 | $1.02M | Sell |
14,550
-800
| -5% | -$57.6K | 0.04% | 367 |
|
|
2018
Q1 | $1.07M | Sell |
15,350
-12,450
| -45% | -$862K | 0.04% | 382 |
|
|
2017
Q4 | $1.93M | Sell |
27,800
-3,244
| -10% | -$219K | 0.07% | 244 |
|
|
2017
Q3 | $2.1M | Buy |
31,044
+8,372
| +37% | +$529K | 0.09% | 209 |
|
|
2017
Q2 | $1.55M | Sell |
22,672
-6,136
| -21% | -$401K | 0.07% | 254 |
|
|
2017
Q1 | $1.79M | Buy |
28,808
+9,724
| +51% | +$566K | 0.08% | 222 |
|
|
2016
Q4 | $1.04M | Buy |
19,084
+730
| +4% | +$41.5K | 0.05% | 409 |
|
|
2016
Q3 | $1.21M | Buy |
18,354
+1,518
| +9% | +$99.2K | 0.06% | 315 |
|
|
2016
Q2 | $1.02M | Sell |
16,836
-4,232
| -20% | -$246K | 0.05% | 382 |
|
|
2016
Q1 | $1.19M | Buy |
21,068
+1,150
| +6% | +$69.1K | 0.06% | 289 |
|
|
2015
Q4 | $1.35M | Buy |
19,918
+2,852
| +17% | +$187K | 0.06% | 254 |
|
|
2015
Q3 | $1.09M | Sell |
17,066
-8,694
| -34% | -$572K | 0.06% | 264 |
|
|
2015
Q2 | $1.64M | Buy |
25,760
+598
| +2% | +$40.9K | 0.07% | 236 |
|
|
2015
Q1 | $1.72M | Buy |
25,162
+4,830
| +24% | +$336K | 0.07% | 259 |
|
|
2014
Q4 | $1.43M | Sell |
20,332
-4,454
| -18% | -$319K | 0.06% | 298 |
|
|
2014
Q3 | $1.77M | Sell |
24,786
-14,094
| -36% | -$1.03M | 0.08% | 214 |
|
|
2014
Q2 | $2.89M | Buy |
38,880
+6,804
| +21% | +$492K | 0.13% | 133 |
|
|
2014
Q1 | $2.08M | Sell |
32,076
-1,728
| -5% | -$112K | 0.09% | 170 |
|
|
2013
Q4 | $2.01M | Buy |
33,804
+4,241
| +14% | +$230K | 0.09% | 178 |
|
|
2013
Q3 | $1.53M | Buy |
29,563
+13,254
| +81% | +$666K | 0.08% | 230 |
|
|
2013
Q2 | $771K | Buy |
+16,309
| New | +$830K | 0.05% | 377 |
|
Other funds holding AZN
EP
IA
Profund Advisors's AZN Position: Q2 2026 in Review
Profund Advisors reduced its AstraZeneca (AZN) stake by 2.8% in Q2 2026, selling an estimated $19K and leaving 3,499 shares worth $663K. The position accounts for 0.02% of the portfolio, ranked #458.
Profund Advisors first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.97M in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Profund Advisors held 3,499 shares of AstraZeneca worth $663K as of Q2 2026.
- Profund Advisors sold 101 AstraZeneca shares in Q2 2026, an estimated $19K.
- AstraZeneca made up 0.02% of Profund Advisors's portfolio in Q2 2026, its #458 holding.
- Profund Advisors first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- Profund Advisors's AstraZeneca position peaked at $4.97M in Q4 2025.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.